In millions, except per share amounts | First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Year | ||||||||||||||
2013: | |||||||||||||||||||
Net revenues | $ | 30,751 | $ | 31,248 | $ | 31,932 | $ | 32,830 | $ | 126,761 | |||||||||
Gross profit | 5,577 | 5,841 | 6,027 | 6,338 | 23,783 | ||||||||||||||
Operating profit | 1,694 | 1,972 | 2,154 | 2,217 | 8,037 | ||||||||||||||
Income from continuing operations | 954 | 1,125 | 1,255 | 1,266 | 4,600 | ||||||||||||||
Loss from discontinued operations, net of tax | — | (1 | ) | (6 | ) | (1 | ) | (8 | ) | ||||||||||
Net income | 954 | 1,124 | 1,249 | 1,265 | 4,592 | ||||||||||||||
Net loss attributable to noncontrolling interest | — | — | — | — | — | ||||||||||||||
Net income attributable to CVS Caremark | $ | 954 | $ | 1,124 | $ | 1,249 | $ | 1,265 | $ | 4,592 | |||||||||
Basic earnings per common share: | |||||||||||||||||||
Income from continuing operations attributable to CVS Caremark | $ | 0.77 | $ | 0.92 | $ | 1.03 | $ | 1.06 | $ | 3.78 | |||||||||
Loss from discontinued operations attributable to CVS Caremark | $ | — | $ | — | $ | — | $ | — | $ | (0.01 | ) | ||||||||
Net income attributable to CVS Caremark | $ | 0.77 | $ | 0.92 | $ | 1.03 | $ | 1.06 | $ | 3.77 | |||||||||
Diluted Earnings per common share: | |||||||||||||||||||
Income from continuing operations attributable to CVS Caremark | $ | 0.77 | $ | 0.91 | $ | 1.02 | $ | 1.05 | $ | 3.75 | |||||||||
Loss from discontinued operations attributable to CVS Caremark | $ | — | $ | — | $ | — | $ | — | $ | (0.01 | ) | ||||||||
Net income attributable to CVS Caremark | $ | 0.77 | $ | 0.91 | $ | 1.02 | $ | 1.05 | $ | 3.74 | |||||||||
Dividends per common share | $ | 0.2250 | $ | 0.2250 | $ | 0.2250 | $ | 0.2250 | $ | 0.9000 | |||||||||
Stock price: (New York Stock Exchange) | |||||||||||||||||||
High | $ | 56.07 | $ | 60.70 | $ | 62.36 | $ | 71.99 | $ | 71.99 | |||||||||
Low | $ | 49.00 | $ | 53.94 | $ | 56.68 | $ | 56.32 | $ | 49.00 | |||||||||
In millions, except per share amounts | First Quarter | Second Quarter | Third Quarter | Fourth Quarter | Year | ||||||||||||||
2012: | |||||||||||||||||||
Net revenues | $ | 30,792 | $ | 30,694 | $ | 30,237 | $ | 31,397 | $ | 123,120 | |||||||||
Gross profit | 5,106 | 5,443 | 5,645 | 6,294 | 22,488 | ||||||||||||||
Operating profit | 1,397 | 1,702 | 1,812 | 2,299 | 7,210 | ||||||||||||||
Income from continuing operations | 772 | 962 | 1,010 | 1,125 | 3,869 | ||||||||||||||
Income (loss) from discontinued operations, net of tax | (1 | ) | (1 | ) | (5 | ) | — | (7 | ) | ||||||||||
Net income | 771 | 961 | 1,005 | 1,125 | 3,862 | ||||||||||||||
Net loss attributable to noncontrolling interest | 1 | 1 | — | — | 2 | ||||||||||||||
Net income attributable to CVS Caremark | $ | 772 | $ | 962 | $ | 1,005 | $ | 1,125 | $ | 3,864 | |||||||||
Basic earnings per common share: | |||||||||||||||||||
Income from continuing operations attributable to CVS Caremark | $ | 0.60 | $ | 0.75 | $ | 0.80 | $ | 0.91 | $ | 3.05 | |||||||||
Income (loss) from discontinued operations attributable to CVS Caremark | $ | — | $ | — | $ | — | $ | — | $ | (0.01 | ) | ||||||||
Net income attributable to CVS Caremark | $ | 0.59 | $ | 0.75 | $ | 0.79 | $ | 0.91 | $ | 3.04 | |||||||||
Diluted Earnings per common share: | |||||||||||||||||||
Income from continuing operations attributable to CVS Caremark | $ | 0.59 | $ | 0.75 | $ | 0.79 | $ | 0.90 | $ | 3.02 | |||||||||
Income (loss) from discontinued operations attributable to CVS Caremark | $ | — | $ | — | $ | — | $ | — | $ | (0.01 | ) | ||||||||
Net income attributable to CVS Caremark | $ | 0.59 | $ | 0.75 | $ | 0.79 | $ | 0.90 | $ | 3.02 | |||||||||
Dividends per common share | $ | 0.1625 | $ | 0.1625 | $ | 0.1625 | $ | 0.1625 | $ | 0.650 | |||||||||
Stock price: (New York Stock Exchange) | |||||||||||||||||||
High | $ | 45.88 | $ | 46.93 | $ | 48.69 | $ | 49.80 | $ | 49.80 | |||||||||
Low | $ | 41.01 | $ | 43.08 | $ | 43.65 | $ | 44.33 | $ | 41.01 | |||||||||